-
Something wrong with this record ?
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
P. Krafcikova, J. Silhan, R. Nencka, E. Boura,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
CZ.02.1.01/0.0/0.0/16_019/0000729
EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) - International
NLK
Directory of Open Access Journals
from 2015
Free Medical Journals
from 2010
Nature Open Access
from 2010-12-01
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2010-01-01
Open Access Digital Library
from 2015-01-01
Open Access Digital Library
from 2015-01-01
Medline Complete (EBSCOhost)
from 2012-11-01
Health & Medicine (ProQuest)
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Adenosine analogs & derivatives metabolism pharmacology MeSH
- Betacoronavirus enzymology MeSH
- Models, Chemical MeSH
- Enzyme Inhibitors metabolism pharmacology MeSH
- Catalytic Domain MeSH
- Coronavirus Infections virology MeSH
- Crystallography, X-Ray MeSH
- Humans MeSH
- Methyltransferases chemistry metabolism MeSH
- Models, Molecular MeSH
- Pandemics MeSH
- RNA Caps MeSH
- RNA, Viral metabolism MeSH
- RNA Stability MeSH
- Pneumonia, Viral virology MeSH
- Viral Nonstructural Proteins chemistry metabolism MeSH
- Viral Regulatory and Accessory Proteins chemistry metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic. 2'-O-RNA methyltransferase (MTase) is one of the enzymes of this virus that is a potential target for antiviral therapy as it is crucial for RNA cap formation; an essential process for viral RNA stability. This MTase function is associated with the nsp16 protein, which requires a cofactor, nsp10, for its proper activity. Here we show the crystal structure of the nsp10-nsp16 complex bound to the pan-MTase inhibitor sinefungin in the active site. Our structural comparisons reveal low conservation of the MTase catalytic site between Zika and SARS-CoV-2 viruses, but high conservation of the MTase active site between SARS-CoV-2 and SARS-CoV viruses; these data suggest that the preparation of MTase inhibitors targeting several coronaviruses - but not flaviviruses - should be feasible. Together, our data add to important information for structure-based drug discovery.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024872
- 003
- CZ-PrNML
- 005
- 20201222153600.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41467-020-17495-9 $2 doi
- 035 __
- $a (PubMed)32709887
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Krafcikova, Petra $u Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo nam. 2., 166 10, Prague 6, Czech Republic.
- 245 10
- $a Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin / $c P. Krafcikova, J. Silhan, R. Nencka, E. Boura,
- 520 9_
- $a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic. 2'-O-RNA methyltransferase (MTase) is one of the enzymes of this virus that is a potential target for antiviral therapy as it is crucial for RNA cap formation; an essential process for viral RNA stability. This MTase function is associated with the nsp16 protein, which requires a cofactor, nsp10, for its proper activity. Here we show the crystal structure of the nsp10-nsp16 complex bound to the pan-MTase inhibitor sinefungin in the active site. Our structural comparisons reveal low conservation of the MTase catalytic site between Zika and SARS-CoV-2 viruses, but high conservation of the MTase active site between SARS-CoV-2 and SARS-CoV viruses; these data suggest that the preparation of MTase inhibitors targeting several coronaviruses - but not flaviviruses - should be feasible. Together, our data add to important information for structure-based drug discovery.
- 650 _2
- $a adenosin $x analogy a deriváty $x metabolismus $x farmakologie $7 D000241
- 650 _2
- $a Betacoronavirus $x enzymologie $7 D000073640
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a koronavirové infekce $x virologie $7 D018352
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a inhibitory enzymů $x metabolismus $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a methyltransferasy $x chemie $x metabolismus $7 D008780
- 650 _2
- $a chemické modely $7 D008956
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a virová pneumonie $x virologie $7 D011024
- 650 _2
- $a RNA čepičky $7 D012315
- 650 _2
- $a stabilita RNA $7 D020871
- 650 _2
- $a RNA virová $x metabolismus $7 D012367
- 650 _2
- $a virové nestrukturální proteiny $x chemie $x metabolismus $7 D017361
- 650 _2
- $a virové regulační a přídatné proteiny $x chemie $x metabolismus $7 D054334
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Silhan, Jan $u Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo nam. 2., 166 10, Prague 6, Czech Republic.
- 700 1_
- $a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo nam. 2., 166 10, Prague 6, Czech Republic. nencka@uochb.cas.cz.
- 700 1_
- $a Boura, Evzen $u Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo nam. 2., 166 10, Prague 6, Czech Republic. boura@uochb.cas.cz.
- 773 0_
- $w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 11, č. 1 (2020), s. 3717
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32709887 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153556 $b ABA008
- 999 __
- $a ok $b bmc $g 1599017 $s 1115558
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 11 $c 1 $d 3717 $e 20200724 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000729 $p EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) $2 International
- LZP __
- $a Pubmed-20201125